查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832493

心臟復健設備市場：按產品類型、最終用戶和服務 - 2025 年至 2032 年全球預測

Cardiac Rehabilitation Device Market by Product Type, End User, Service - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年心臟復健設備市場將成長至 48.7 億美元，複合年成長率為 8.34%。

主要市場統計數據
基準年2024年 25.6億美元
預計2025年 27.8億美元
預測年份：2032年 48.7億美元
複合年成長率（%） 8.34%

定義臨床實踐與相關復健技術的不斷發展的交集，以重塑循環系統患者的康復途徑

心臟復健技術處於醫療設備工程、數位健康和​​以患者為中心的護理的交叉領域。近期的技術創新週期使得持續的生理監測、有針對性的治療性介入以及日益複雜的遠端干預成為可能，將設備的覆蓋範圍擴展到了臨床環境之外。數據分析、互通性標準和以使用者為中心的設計等領域的平行發展與這些進步相輔相成，共同重塑了循環系統團隊在整個護理過程中提供復健服務的方式。

透過監測設備（例如門診心電圖和多參數平台）以及針對院外安全使用而最佳化的復健設備，復健模式已從以住院患者為中心的模式轉變為融合診所監管和家庭治療方案的混合模式。同時，電刺激和呼吸治療工具等治療設備也正在被改造，以實現可擴展的、受監管的家庭使用。設備小型化、連接性和遠端服務交付的融合，正在為提高依從性、減少再入院率以及根據個人康復軌跡調整康復強度開闢新的途徑。

鑑於這些動態，從臨床領導者到設備開發商的相關人員正在重新審視護理路徑和籌資策略。付款人和醫療系統越來越關注能夠證明臨床結果和營運效率的證據。因此，心臟復健設備領域正在快速發展，影響臨床通訊協定、採購決策和病患參與模式。

感測器聚合、緊湊型復健設備和不斷發展的政策如何加速混合心臟復健模型和遠端臨床監測

由於技術的成熟、政策的演變以及醫療服務的重新設計，心臟復健設備的格局正在轉變。在技​​術層面，感測器保真度、電池效率和即時分析的融合使監測設備能夠提供具有臨床意義的數據流，從而為自適應復健計畫提供資訊。因此，臨床醫生開始將遠距心電圖監測、多參數趨勢分析和脈搏血氧計回饋納入標準化通訊協定，以支持從偶發性評估到持續結果追蹤的過渡。

同時，復健設備製造商正在重新考慮外形規格和易用性，以支持在家中安全、無人監督的使用。攜帶式自行車測功儀和緊湊型跑步機正在整合曾經僅用於臨床環境的安全和遠端監控功能。治療設備也正在與遠端醫療工作流程相整合，電刺激和呼吸治療模式現在以協作方案的形式提供，並由虛擬指導和臨床醫生監督支援。此類產品層面的創新正在推動新的服務模式，這些模式強調遠端監控服務、遠端醫療諮詢和主動維護合約。

最後，監管途徑和報銷框架開始反映出向混合康復的轉變。付款方越來越容易接受與降低再入院率和改善功能結果相關的證據，監管機構也正在明確對軟體更新、資料安全和設備互通性的期望。這些變化正在加速遠距復健的採用，促進設備製造商和數位醫療服務提供者之間的夥伴關係，並鼓勵衛生系統試行大規模遠距復健計畫。

針對 2025 年美國關稅變化進行商業性和營運調整，強調供應彈性、模組化設計和捆綁服務策略

美國近期針對2025年的貿易和關稅發展，為心臟復健和監測設備製造商、供應商和醫療系統採購商帶來了新的商業性考量。供應鏈相關人員正在重新評估感測器模組、電源管理IC和專用復健機械等關鍵組件的採購決策，以降低成本風險並保持生產的連續性。為此，一些設備製造商正在實現組件採購多元化，調整材料清單，並與戰略供應商簽訂長期契約，以應對潛在的關稅相關成本波動。

在採購調整的同時，製造商透過模組化產品架構和增加相容子系統的使用，加快了供應彈性的設計。這種方法降低了單一來源的脆弱性，並加快了供應商的重新認證流程。此外，擁有全球製造地的製造商正在策略性地將生產轉移到貿易條件優惠的國家或更靠近終端市場的國家，以縮短前置作業時間並降低物流風險。對於醫療系統和採購部門而言，這種轉變凸顯了總擁有成本分析的重要性，該分析不僅考慮採購價格，還考慮物流、維護和備件供應情況。

最後，服務和軟體元件作為價值槓桿正日益受到關注。遠端監控服務和遠端保健支援的維護合約有助於平滑收益影響，並為買家提供可預測的成本結構。因此，商業談判越來越注重包含設備、軟體和持續服務的捆綁產品，以便在瞬息萬變的交易環境中確保臨床的連續性和財務可預測性。

將設備模式、護理環境和服務連結起來的多維細分觀點揭示了臨床價值和採購優先順序的交匯點

細緻的細分框架明確了臨床影響和機會最集中的領域。就產品類型而言，市場細分為監測、復健和治療設備。監測設備包括血壓計、心電圖監測儀、多參數監測儀和脈動式血氧監測儀系統，每種設備在復健工作流程中都發揮獨特的監測和分類作用。復健設備包括臂式測功儀、自行車測功儀和跑步機，並根據治療目標、患者活動需求和空間考量而有所不同。治療設備包括電刺激、呼吸療法和超音波療法，每種設備都為康復和功能恢復提供特定於模式的益處。

從最終用戶的角度來看，診所、居家醫療機構、醫院和復健中心是部署設備的主要醫療保健環境。在診所中，心臟復健診所和物理治療診所有不同的臨床通訊協定和採購偏好。同時，在居家照護環境中，看護者輔助和自我管理場景對易用性和遠端監控的要求也有所不同。醫院和復健中心通常優先考慮與電子健康記錄和集中監控平台的整合，強調互通性和臨床醫生工作流程的效率。

服務細分進一步明確了商業模式，區分了維護和支援服務、遠端監控服務和遠端醫療服務。維護和支援服務通常採用年度服務合約或按事件付費協議的形式，為買家提供不同程度的可預測性。遠端監控服務涵蓋數據分析和即時警報等多種服務，支援主動的臨床介入。遠端醫療服務包括遠距指導和虛擬會診，擴大臨床醫生的可近性並支持患者堅持用藥。產品類型、最終用戶和服務這三個維度的結合，為整個心臟復健生態系統的需求促進因素和採購決策提供了多維度的觀點。

區域採用模式和政策主導的優先事項決定了臨床整合、採購偏好和全球市場部署的可行性

區域動態正在塑造各主要地區不同的採用曲線和投資重點。在美洲，醫療系統正在試驗混合護理模式，並強調以結果為導向的主導，優先考慮能夠降低再入院率並改善患者報告結果的解決方案。因此，能夠將監測數據整合到臨床工作流程和計費系統中的設備供應商正獲得更大的關注。同時，北美的報銷趨勢和私人付款人計劃繼續影響具有商業性可行性的遠端醫療和遠端監測服務的類型。

多樣化的監管環境和參差不齊的醫療基礎設施水平，使得歐洲、中東和非洲地區呈現出高度分化的格局。西歐市場正經歷遠端醫療與居家復健的快速融合，同時人們對資料保護和醫療設備監管寄予厚望；而該地區的新興市場則優先考慮經濟高效、性能強大的設備，以應對門診病人和社區醫療資源的限制。在許多歐洲、中東和非洲地區，公共衛生計劃和區域夥伴關係正在推動試驗計畫，評估可擴展的遠距復健作為擴大醫療覆蓋範圍的一種手段。

亞太地區既有患者數量龐大、正在採用先進數位醫療模式的都市區，也有人口眾多、注重價格實惠、耐用設備的農村地區。在亞太地區的多個市場，政府正在投資遠端醫療基礎設施，並獎勵能夠減輕醫院負擔的數位解決方案。綜合來看，這些區域模式揭示了製造商、通路合作夥伴和服務提供者在努力根據當地臨床工作流程、報銷環境和部署實際情況調整產品功能時所採取的細分策略。

硬體、軟體和服務整合的競爭動態有利於互通性、網路安全性和以結果為中心的夥伴關係關係

心臟復健設備領域的競爭態勢體現在老牌醫療設備製造商、專業復健設備製造商以及新興數位醫療參與企業的混合競爭。傳統設備製造商通常利用成熟的臨床關係、廣泛的服務網路和監管專業知識，在醫院和機構管道中保持存在。這些老牌廠商正擴大與軟體公司和遠端醫療提供者合作，在其設備組合中增加遠端監控和虛擬護理功能，從而擴大售後服務收益並提高臨床連續性。

同時，敏捷的新興企業和軟體優先型公司正在透過專注於使用者體驗、數據分析和快速迭代來顛覆傳統的價值提案。這些參與企業通常與付款方和綜合醫療系統合作進行試點，檢驗結果並證明成本效益，然後透過合作夥伴關係和許可協議進行擴展。通路合作夥伴和服務提供者在推動採用、提供安裝、臨床醫生培訓、持續設備管理等方面發揮核心作用。此外，契約製造製造商和全球供應商在管理組件可用性和加快產品迭代周期方面也發揮著至關重要的作用。

策略差異化取決於能否提供整合提案，將可靠的硬體、安全的資料流和可操作的臨床工作流程融為一體。能夠展現互通性、強大的網路安全實務和檢驗的臨床路徑的公司，更有可能獲得採購委員會的更多認可。同時，投資於可擴展服務模式（例如遠端監控訂閱和結果主導的維護）的公司，將能夠建立永續的經常性收益來源並深化客戶關係。

設備製造商和服務供應商應優先考慮的策略槓桿，以推動可擴展的採用、供應彈性和臨床檢驗的價值提案

產業領導者應優先考慮能夠加速安全、可擴展部署並增強商業性韌性的策略。首先，採用模組化架構和清晰的互通性標準設計產品，可以減少與醫院IT系統的整合摩擦，並支援在各種臨床環境中快速採用。此外，強調強大的網路安全、資料管治和合規框架對於與臨床醫生和醫療系統買家建立信任也至關重要。

其次，領導者應擴展服務範圍，並將設備與遠端監控、遠端醫療指導和分級維護合約捆綁在一起，以協調供應商和購買者之間的獎勵。捆綁式解決方案可以透過產生可預測的業務收益並提高客戶維繫來降低資費和物流的不確定性。第三，透過可操作的臨床研究和真實世界證據計畫投資於證據生成，可以強化價值提案，並簡化與付款人的報銷談判。這些研究應著重於功能結果、依從性指標和健康經濟影響，以引起決策者的共鳴。

最後，追求靈活的生產佈局和多元化的供應鏈，可以降低貿易中斷和零件短缺的風險。與數位醫療公司、本地經銷商和臨床領導者建立策略夥伴關係，可以加速市場准入，並支援培訓和支援的在地化。透過執行這些優先事項，產業相關人員可以改善患者治療效果，減少醫療保健提供者的營運摩擦，並在動態環境中建立可防禦的商業模式。

調查方法結合二手文獻、監管調查和相關人員訪談，提供可行的見解並檢驗醫療設備趨勢

本分析的基礎研究將系統性的二次研究與有針對性的一次研究相結合，以確保研究的穩健性和實踐相關性。二次研究包括對同行評審的臨床文獻、監管指南文件、醫療設備技術標準以及公共衛生機構關於遠端醫療和遠端監控的聲明的全面回顧。這項基礎研究揭示了有關設備模式、臨床最佳實踐和監管現狀的事實，並補充了過時的產品摘要和技術規格，為近期的產品創新提供了背景資訊。

主要研究活動包括對臨床醫生、生物醫學工程師、採購專家以及醫療機構高管進行結構化訪談，以了解目前採用該技術的促進因素、工作流程限制和服務偏好。訪談對象特意來自醫院、復健中心、診所和居家照護機構，以反映採用情況的多樣性。此外，與設備設計師和供應鏈經理進行的技術諮詢，提供了關於組件採購、製造權衡以及在傳統臨床環境之外部署的設計策略的見解。

資料合成包括將訪談中獲得的定性見解與二手證據進行三角檢驗，以檢驗新出現的主題。品管包括訪談結果的交叉檢驗、專家反覆評審以及與監管指南的一致性檢查。在整個過程中，調查方法透明度和倫理考量指南資料收集，確保受訪者的隱私和結論的完整性。

整合技術、臨床和商業性需求，定義可擴展混合心臟復健模式的道路

心臟復健設備及相關服務正在重塑患者的康復，透過實現持續監測、將臨床醫生的監督延伸至診所之外以及支持個人化治療方法。監測設備、復健設備和治療模式之間的相互作用，結合遠端監測和遠端醫療服務，創建了一體化的護理路徑，從而提高了依從性並簡化了臨床醫生的工作流程。儘管由於基礎設施和政策環境的不同，各地區最合適的配置也存在差異，但混合型、數據主導復健的基本趨勢始終保持一致。

商業性，供應鏈的韌性、對服務主導經營模式的投資以及臨床價值的清晰展示將使市場參與企業脫穎而出。監管的一致性和互通性對於更廣泛的應用仍然至關重要，而可操作證據的產生將有助於報銷討論和臨床認可。隨著相關人員重塑採購和醫療服務交付方式，對於那些能夠平衡設備可靠性、軟體驅動的醫療協調和可擴展服務營運的創新者來說，存在著明顯的機會。

摘要，設備創新、數位化服務和照護模式重塑的融合，為改善心臟復健結果提供了一條持久的途徑。那些能夠深思熟慮地整合這些要素，同時管理營運和監管複雜性的機構，將能夠引領這個不斷發展的生態系統。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 透過整合穿戴式感測器數據和人工智慧指導，擴展針對心臟病發作後患者的遠距復健平台
  • 實施具有即時心電圖分析功能的遠端患者監護系統，以便在復健期間及早發現心臟異常
  • 開發結合虛擬實境鍛鍊模組和遊戲化的家庭數位療法，以促進患者遵守復健計劃
  • 將區塊鏈保護的患者記錄整合到心臟復健設備中，以增強醫療保健提供者之間的資料隱私和互通性
  • 增加對可攜式低功耗心臟輔助設備的投資，以實現遠端、連續的血流動力學監測和個人化運動處方

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 心臟復健設備市場（依產品類型）

  • 監控設備
    • 血壓計
    • 心電圖監測儀
    • 多參數監視器
    • 脈動式血氧監測儀系統
  • 復健設備
    • 臂力計
    • 自行車測功儀
    • 跑步機
  • 治療設備
    • 電刺激設備
    • 呼吸治療裝置
    • 超音波治療儀

9. 心臟復健設備市場（依最終用戶）

  • 診所
    • 心臟復健診所
    • 物理治療診所
  • 居家照護環境
    • 看護者支持
    • 自我管理
  • 醫院
  • 復健中心

第 10 章：心臟復健設備市場（按服務）

  • 維護和支援
    • 年度服務協議
    • 按事件付費
  • 遠端監控服務
    • 數據分析
    • 即時警報
  • 遠端醫療服務
    • 遠距輔導
    • 虛擬諮詢

第 11 章：心臟復健設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 12 章：心臟復健設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 13 章：心臟復健設備市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • General Electric Company
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Medtronic plc
    • Abbott Laboratories
    • Nihon Kohden Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Hill-Rom Holdings, Inc.
    • BioTelemetry, Inc.
    • Philips Healthcare
Product Code: MRR-433AB1DC2894

The Cardiac Rehabilitation Device Market is projected to grow by USD 4.87 billion at a CAGR of 8.34% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.56 billion
Estimated Year [2025] USD 2.78 billion
Forecast Year [2032] USD 4.87 billion
CAGR (%) 8.34%

Defining the evolving crossroads between clinical practice and connected rehabilitation technology that is reshaping patient recovery pathways in cardiology

Cardiac rehabilitation technology is at the intersection of medical device engineering, digital health, and patient-centered care. Recent innovation cycles have expanded the scope of devices beyond clinical settings, enabling continuous physiological monitoring, targeted therapeutic interventions, and increasingly sophisticated remote engagement. These advancements are complemented by parallel developments in data analytics, interoperability standards, and user-centered design, which together are reshaping how cardiology teams deliver rehabilitation across the continuum of care.

Transitioning from inpatient-centric rehabilitation paradigms to hybrid models that blend clinic-based supervision with home-based regimens has been enabled by monitoring devices such as ambulatory ECGs and multi-parameter platforms, as well as by rehabilitation equipment that is optimized for safe use outside hospital wards. At the same time, therapeutic devices including electrical stimulation and respiratory therapy tools are being adapted for scalable, supervised home use. This confluence of device miniaturization, connectivity, and remote service delivery is creating new pathways for improving adherence, reducing rehospitalization, and tailoring rehabilitation intensity to individual recovery trajectories.

Given these dynamics, stakeholders from clinical leaders to device developers are re-examining care pathways and procurement strategies. Payers and health systems are increasingly attentive to evidence demonstrating clinical outcomes and operational efficiencies. As a result, the cardiac rehabilitation device landscape is evolving rapidly, with implications for clinical protocols, purchasing decisions, and patient engagement models.

How sensor convergence, compact rehabilitation equipment, and evolving policy are accelerating hybrid cardiac rehab models and remote clinical oversight

The landscape of cardiac rehabilitation devices is undergoing transformative shifts driven by technological maturation, policy evolution, and care delivery redesign. At the technological level, convergence between sensor fidelity, battery efficiency, and real-time analytics has enabled monitoring devices to provide clinically meaningful data streams that can inform adaptive rehabilitation programs. Consequently, clinicians are beginning to incorporate remote ECG monitoring, multi-parameter trend analysis, and pulse oximetry feedback into standardized protocols, which supports a transition from episodic assessments to continuous outcome tracking.

Concurrently, rehabilitation equipment manufacturers are rethinking form factors and usability to support safe unsupervised use at home; portable cycle ergometers and compact treadmills now incorporate safety features and remote supervision capabilities that were once exclusive to clinical settings. Therapeutic devices are also becoming more integrated with telehealth workflows, so electrical stimulation and respiratory therapy modalities can be delivered in coordinated regimens supported by virtual coaching and clinician oversight. These product-level innovations are catalyzing new service models that emphasize remote monitoring services, telehealth consultations, and proactive maintenance agreements.

Finally, regulatory pathways and reimbursement frameworks are beginning to reflect the shift toward hybrid rehabilitation. Payers are more receptive to evidence of reduced readmissions and improved functional outcomes, while regulators are clarifying expectations for software updates, data security, and device interoperability. Together, these changes are accelerating adoption, encouraging partnerships between device makers and digital health providers, and prompting health systems to pilot scaled remote rehabilitation programs.

Commercial and operational adjustments in response to 2025 United States tariff shifts emphasizing supply resilience, modular design, and bundled service strategies

Recent trade and tariff developments in the United States in 2025 have introduced an additional layer of commercial calculus for manufacturers, suppliers, and health system purchasers of cardiac rehabilitation equipment and monitoring devices. Supply chain actors are reassessing sourcing decisions for key components such as sensor modules, power management ICs, and specialized rehabilitation mechanics to mitigate cost exposure and maintain manufacturing continuity. In response, several device makers have diversified component sourcing, adjusted bill-of-material allocations, and negotiated longer-term agreements with strategic suppliers to buffer against potential tariff-related cost fluctuations.

Parallel to procurement adjustments, manufacturers have accelerated design for supply resilience by modularizing product architectures and increasing the use of interchangeable subsystems. This approach reduces single-source vulnerability and enables faster supplier requalification processes. Moreover, manufacturers with global manufacturing footprints are strategically shifting production runs to jurisdictions with favorable trade terms or closer proximity to end markets to reduce lead times and logistical risk. For health systems and procurement offices, these shifts have elevated the importance of total cost of ownership analyses that account not only for purchase price but also for logistics, maintenance, and spare-part availability.

Finally, services and software components have gained attention as value levers; remote monitoring services and telehealth-enabled maintenance contracts help smooth revenue impacts and offer predictable cost structures for buyers. As a result, commercial negotiations increasingly emphasize bundled offerings that incorporate devices, software, and ongoing services to provide clinical continuity and fiscal predictability in a shifting trade environment.

A multi-dimensional segmentation perspective linking device modalities, care settings, and services to reveal where clinical value and procurement priorities intersect

A nuanced segmentation framework provides clarity on where clinical impact and commercial opportunity are most concentrated. When examining product type, the market differentiates between monitoring devices, rehabilitation equipment, and therapeutic devices. Monitoring devices encompass blood pressure monitors, ECG monitors, multi-parameter monitors, and pulse oximeters, each serving distinct monitoring and triage roles in rehabilitation workflows. Rehabilitation equipment spans arm ergometers, cycle ergometers, and treadmills, which differ by therapeutic focus, patient mobility requirements, and space considerations. Therapeutic devices include electrical stimulation devices, respiratory therapy devices, and ultrasound therapy devices, each offering modality-specific benefits for recovery and functional restoration.

In terms of end users, clinics, home care settings, hospitals, and rehabilitation centers represent the primary care environments where devices are deployed. Within clinics, cardiac rehabilitation clinics and physical therapy clinics present different clinical protocols and procurement preferences, while home care settings split between caregiver-assisted and self-administered scenarios that drive differing requirements for usability and remote supervision. Hospitals and rehabilitation centers often prioritize integration with electronic health records and centralized monitoring platforms, emphasizing interoperability and clinician workflow efficiency.

Service segmentation further clarifies commercial models, distinguishing maintenance and support services, remote monitoring services, and telehealth services. Maintenance and support can be structured as annual service contracts or pay-per-incident agreements, providing varying degrees of predictability for buyers. Remote monitoring services range from data analytics to real-time alerts, enabling proactive clinical interventions. Telehealth services include remote coaching and virtual consultations that extend clinician reach and support adherence. Together, these three lenses-product type, end user, and service-create a multi-dimensional view of demand drivers and procurement decision-making across the cardiac rehabilitation ecosystem.

Regional adoption patterns and policy-driven priorities that determine clinical integration, procurement preferences, and deployment feasibility across global markets

Regional dynamics are shaping adoption curves and investment priorities in distinct ways across major geographies. In the Americas, health systems are experimenting with hybrid care models and placing emphasis on outcome-driven procurement, which favors solutions that demonstrate reductions in rehospitalization and improvements in patient-reported outcomes. As a result, device providers that can integrate monitoring data into clinical workflows and billing systems are achieving greater traction. Meanwhile, North American reimbursement trends and private payer programs continue to influence the types of telehealth and remote monitoring services that are commercially viable.

In Europe, Middle East & Africa, diverse regulatory environments and varying levels of healthcare infrastructure produce a heterogeneous landscape. Western European markets are advancing rapid integration of telemetry and home-based rehabilitation with strong data protection and medical device regulatory expectations, while emerging markets within the region are prioritizing cost-effective, robust devices that address capacity constraints in outpatient and community settings. In many EMEA jurisdictions, public health initiatives and regional partnerships are driving pilot programs that assess scalable remote rehabilitation as a means to broaden access.

Asia-Pacific presents a combination of high-volume urban centers adopting advanced digital health models and large rural populations where low-cost, durable devices are prioritized. Governments in several APAC markets are investing in telehealth infrastructure and incentivizing digital solutions that decrease hospital burden. Collectively, these regional patterns inform segmentation strategies for manufacturers, channel partners, and service providers seeking to match product capabilities to local clinical workflows, reimbursement environments, and deployment realities.

Competitive landscape dynamics driven by integration of hardware, software, and services that favor interoperability, cybersecurity, and outcome-focused partnerships

Competitive dynamics within the cardiac rehabilitation device sector are characterized by a mix of established medical device manufacturers, specialized rehabilitation equipment producers, and emergent digital health entrants. Legacy device manufacturers typically leverage established clinical relationships, broad service networks, and regulatory expertise to maintain presence in hospital and institutional channels. These incumbents are increasingly partnering with software firms and telehealth providers to add remote monitoring and virtual care capabilities to their device portfolios, thereby extending after-sales revenue and improving clinical continuity.

At the same time, agile startups and software-first companies are disrupting traditional value propositions by focusing on user experience, data analytics, and rapid iteration. These entrants often pilot with payers and integrated health systems to validate outcomes and prove cost-effectiveness, then scale through partnerships or licensing arrangements. Channel partners and service providers play a central role in enabling adoption, offering installation, clinician training, and ongoing device management. Additionally, contract manufacturers and global suppliers are critical in managing component availability and enabling faster product iteration cycles.

Strategic differentiation increasingly rests on the ability to deliver integrated propositions that combine reliable hardware, secure data flows, and actionable clinical workflows. Companies that can demonstrate interoperability, robust cybersecurity practices, and validated clinical pathways will find greater openness from procurement committees. Meanwhile, those that invest in scalable service models-such as remote monitoring subscriptions and outcome-driven maintenance-can create sustainable recurring revenue streams and deepen customer relationships.

Prioritized strategic levers for device makers and service providers to drive scalable adoption, supply resilience, and clinically validated value propositions

Industry leaders should prioritize strategies that accelerate safe, scalable deployment while strengthening commercial resilience. Firstly, designing products with modular architectures and clear interoperability standards will reduce integration friction with hospital IT systems and support faster adoption across varied clinical environments. Emphasizing robust cybersecurity, data governance, and compliance frameworks will also be essential to building trust with clinicians and health system purchasers.

Secondly, leaders should expand service offerings to bundle devices with remote monitoring, telehealth coaching, and tiered maintenance contracts that align incentives between providers and purchasers. Bundled solutions can mitigate tariff and logistics uncertainties by creating predictable service revenues and improving client retention. Thirdly, investing in evidence generation-through pragmatic clinical studies and real-world evidence programs-will strengthen value propositions and simplify reimbursement discussions with payers. These studies should focus on functional outcomes, adherence metrics, and health economic impacts to resonate with decision-makers.

Finally, pursuing flexible manufacturing footprints and diversified supply chains can reduce exposure to trade disruptions and component shortages. Strategic partnerships with digital health firms, local distributors, and clinical leaders will accelerate market entry and support localization of training and support. By executing on these priorities, industry participants can enhance patient outcomes, reduce operational friction for care providers, and create defensible commercial models in a dynamic landscape.

A methodologically rigorous approach combining secondary literature, regulatory review, and targeted stakeholder interviews to validate practical insights and device trends

The research underpinning this analysis combines systematic secondary review with targeted primary investigations to ensure robustness and practical relevance. Secondary activities included a comprehensive review of peer-reviewed clinical literature, regulatory guidance documents, technical standards for medical devices, and public statements from health authorities governing telehealth and remote monitoring. This foundation established the factual landscape of device modalities, clinical best practices, and regulatory expectations, which was then supplemented with dated product briefs and technical specifications to contextualize recent product innovations.

Primary research activities incorporated structured interviews with clinicians, biomedical engineers, procurement specialists, and senior executives across care settings to capture current adoption drivers, workflow constraints, and service preferences. Interviews were purposefully sampled across hospitals, rehabilitation centers, clinics, and home care providers to reflect the diversity of deployment contexts. In addition, technical consultations with device designers and supply chain managers provided insight into component sourcing, manufacturing trade-offs, and design strategies that address deployment outside traditional clinical environments.

Data synthesis relied on triangulating qualitative insights from interviews with secondary evidence to validate emerging themes. Quality controls included cross-validation of interview findings, iterative review by subject matter experts, and alignment checks against regulatory guidance. Throughout the process, methodological transparency and ethical considerations guided data collection, ensuring respondent confidentiality and the integrity of conclusions.

Synthesis of technological, clinical, and commercial imperatives that together define the pathway to scalable, hybrid cardiac rehabilitation models

Cardiac rehabilitation devices and their associated services are reshaping patient recovery by enabling continuous monitoring, extending clinician oversight beyond clinic walls, and supporting personalized therapeutic regimens. The interplay between monitoring devices, rehabilitation equipment, and therapeutic modalities-when combined with remote monitoring and telehealth services-creates integrated care pathways that can improve adherence and streamline clinician workflows. Across regions, different infrastructure and policy environments influence which configurations are most appropriate, but the underlying trajectory toward hybrid, data-driven rehabilitation is consistent.

Commercially, resilience in supply chains, investment in service-led business models, and clear demonstration of clinical value will differentiate successful market participants. Regulatory alignment and interoperability will remain crucial for broader adoption, while pragmatic evidence generation will support reimbursement discussions and clinical acceptance. As stakeholders reconfigure procurement and care delivery approaches, there is a clear opportunity for innovators who balance device reliability with software-enabled care coordination and scalable service operations.

In summary, the convergence of device innovation, digital services, and care model redesign presents a durable pathway to improve cardiac rehabilitation outcomes. Organizations that act thoughtfully to integrate these elements, while managing operational and regulatory complexity, will be positioned to lead in this evolving ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of tele-rehabilitation platforms integrating wearable sensor data and AI-guided coaching for post-heart event patients
  • 5.2. Adoption of remote patient monitoring systems with real-time ECG analysis for early detection of cardiac anomalies during rehab sessions
  • 5.3. Development of home-based digital therapeutics combining virtual reality exercise modules and gamification to boost patient adherence to rehab regimens
  • 5.4. Integration of blockchain-secured patient records in cardiac rehab devices to enhance data privacy and interoperability across healthcare providers
  • 5.5. Growing investment in portable low-power cardiac assist devices enabling continuous hemodynamic monitoring and personalized exercise prescriptions remotely

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Rehabilitation Device Market, by Product Type

  • 8.1. Monitoring Devices
    • 8.1.1. Blood Pressure Monitors
    • 8.1.2. EcG Monitors
    • 8.1.3. Multi-Parameter Monitors
    • 8.1.4. Pulse Oximeters
  • 8.2. Rehabilitation Equipment
    • 8.2.1. Arm Ergometer
    • 8.2.2. Cycle Ergometers
    • 8.2.3. Treadmills
  • 8.3. Therapeutic Devices
    • 8.3.1. Electrical Stimulation Devices
    • 8.3.2. Respiratory Therapy Devices
    • 8.3.3. Ultrasound Therapy Devices

9. Cardiac Rehabilitation Device Market, by End User

  • 9.1. Clinics
    • 9.1.1. Cardiac Rehab Clinics
    • 9.1.2. Physical Therapy Clinics
  • 9.2. Home Care Settings
    • 9.2.1. Caregiver-Assisted
    • 9.2.2. Self-Administered
  • 9.3. Hospitals
  • 9.4. Rehabilitation Centers

10. Cardiac Rehabilitation Device Market, by Service

  • 10.1. Maintenance And Support
    • 10.1.1. Annual Service Contracts
    • 10.1.2. Pay-Per-Incident
  • 10.2. Remote Monitoring Services
    • 10.2.1. Data Analytics
    • 10.2.2. Real-Time Alerts
  • 10.3. Telehealth Services
    • 10.3.1. Remote Coaching
    • 10.3.2. Virtual Consultations

11. Cardiac Rehabilitation Device Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Cardiac Rehabilitation Device Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Cardiac Rehabilitation Device Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. General Electric Company
    • 14.3.2. Koninklijke Philips N.V.
    • 14.3.3. Siemens Healthineers AG
    • 14.3.4. Medtronic plc
    • 14.3.5. Abbott Laboratories
    • 14.3.6. Nihon Kohden Corporation
    • 14.3.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 14.3.8. Hill-Rom Holdings, Inc.
    • 14.3.9. BioTelemetry, Inc.
    • 14.3.10. Philips Healthcare

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. CARDIAC REHABILITATION DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CARDIAC REHABILITATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIAC REHABILITATION DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ECG MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MULTI-PARAMETER MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PULSE OXIMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ARM ERGOMETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CYCLE ERGOMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TREADMILLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CARDIAC REHAB CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PHYSICAL THERAPY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CAREGIVER-ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SELF-ADMINISTERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY ANNUAL SERVICE CONTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PAY-PER-INCIDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REAL-TIME ALERTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE COACHING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY VIRTUAL CONSULTATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MONITORING DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REHABILITATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY THERAPEUTIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY MAINTENANCE AND SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY REMOTE MONITORING SERVICES, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY TELEHEALTH SERVICES, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION DEVICE MARKET SIZE, BY PRODUCT TY